Literature DB >> 27856737

Global transformation of erythrocyte properties via engagement of an SH2-like sequence in band 3.

Estela Puchulu-Campanella1,2, Francesco M Turrini3, Yen-Hsing Li1,2, Philip S Low4,2.   

Abstract

Src homology 2 (SH2) domains are composed of weakly conserved sequences of ∼100 aa that bind phosphotyrosines in signaling proteins and thereby mediate intra- and intermolecular protein-protein interactions. In exploring the mechanism whereby tyrosine phosphorylation of the erythrocyte anion transporter, band 3, triggers membrane destabilization, vesiculation, and fragmentation, we discovered a SH2 signature motif positioned between membrane-spanning helices 4 and 5. Evidence that this exposed cytoplasmic sequence contributes to a functional SH2-like domain is provided by observations that: (i) it contains the most conserved sequence of SH2 domains, GSFLVR; (ii) it binds the tyrosine phosphorylated cytoplasmic domain of band 3 (cdb3-PO4) with Kd = 14 nM; (iii) binding of cdb3-PO4 to erythrocyte membranes is inhibited both by antibodies against the SH2 signature sequence and dephosphorylation of cdb3-PO4; (iv) label transfer experiments demonstrate the covalent transfer of photoactivatable biotin from isolated cdb3-PO4 (but not cdb3) to band 3 in erythrocyte membranes; and (v) phosphorylation-induced binding of cdb3-PO4 to the membrane-spanning domain of band 3 in intact cells causes global changes in membrane properties, including (i) displacement of a glycolytic enzyme complex from the membrane, (ii) inhibition of anion transport, and (iii) rupture of the band 3-ankyrin bridge connecting the spectrin-based cytoskeleton to the membrane. Because SH2-like motifs are not retrieved by normal homology searches for SH2 domains, but can be found in many tyrosine kinase-regulated transport proteins using modified search programs, we suggest that related cases of membrane transport proteins containing similar motifs are widespread in nature where they participate in regulation of cell properties.

Entities:  

Keywords:  SH2 domain motif; anion exchanger 1; erythrocyte glycolysis; regulation of transport proteins; tyrosine phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 27856737      PMCID: PMC5137735          DOI: 10.1073/pnas.1611904113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Conservation analysis and structure prediction of the SH2 family of phosphotyrosine binding domains.

Authors:  R B Russell; J Breed; G J Barton
Journal:  FEBS Lett       Date:  1992-06-08       Impact factor: 4.124

Review 2.  Ion transport pathology in the mechanism of sickle cell dehydration.

Authors:  Virgilio L Lew; Robert M Bookchin
Journal:  Physiol Rev       Date:  2005-01       Impact factor: 37.312

Review 3.  The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction.

Authors:  Bernard A Liu; Brett W Engelmann; Piers D Nash
Journal:  FEBS Lett       Date:  2012-05-05       Impact factor: 4.124

Review 4.  Band 3, the human red cell chloride/bicarbonate anion exchanger (AE1, SLC4A1), in a structural context.

Authors:  Reinhart A F Reithmeier; Joseph R Casey; Antreas C Kalli; Mark S P Sansom; Yilmaz Alguel; So Iwata
Journal:  Biochim Biophys Acta       Date:  2016-04-06

5.  Glycolysis in Plasmodium falciparum results in modulation of host enzyme activities.

Authors:  Monika Mehta; Haripalsingh M Sonawat; Shobhona Sharma
Journal:  J Vector Borne Dis       Date:  2006-09       Impact factor: 1.688

6.  A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase.

Authors:  Shane Atwell; Jason M Adams; John Badger; Michelle D Buchanan; Ingeborg K Feil; Karen J Froning; Xia Gao; Jörg Hendle; Kevin Keegan; Barbara C Leon; Hans J Müller-Dieckmann; Vicki L Nienaber; Brian W Noland; Kai Post; K R Rajashankar; Aurora Ramos; Marijane Russell; Stephen K Burley; Sean G Buchanan
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

7.  Increased tyrosine phosphorylation of band 3 in hemoglobinopathies.

Authors:  H T Terra; M J Saad; C R Carvalho; D L Vicentin; F F Costa; S T Saad
Journal:  Am J Hematol       Date:  1998-07       Impact factor: 10.047

8.  Hydrogen ion dynamics in human red blood cells.

Authors:  Pawel Swietach; Teresa Tiffert; Jakob M A Mauritz; Rachel Seear; Alessandro Esposito; Clemens F Kaminski; Virgilio L Lew; Richard D Vaughan-Jones
Journal:  J Physiol       Date:  2010-10-20       Impact factor: 5.182

9.  Irreversible AE1 tyrosine phosphorylation leads to membrane vesiculation in G6PD deficient red cells.

Authors:  Antonella Pantaleo; Emanuela Ferru; Franco Carta; Franca Mannu; Luigi F Simula; Amina Khadjavi; Proto Pippia; Francesco Turrini
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

10.  A phosphotyrosine switch regulates organic cation transporters.

Authors:  Jason A Sprowl; Su Sien Ong; Alice A Gibson; Shuiying Hu; Guoqing Du; Wenwei Lin; Lie Li; Shashank Bharill; Rachel A Ness; Adrian Stecula; Steven M Offer; Robert B Diasio; Anne T Nies; Matthias Schwab; Guido Cavaletti; Eberhard Schlatter; Giuliano Ciarimboli; Jan H M Schellens; Ehud Y Isacoff; Andrej Sali; Taosheng Chen; Sharyn D Baker; Alex Sparreboom; Navjotsingh Pabla
Journal:  Nat Commun       Date:  2016-03-16       Impact factor: 14.919

View more
  8 in total

1.  Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.

Authors:  Panae Noomuna; Mary Risinger; Sitong Zhou; Katie Seu; Yuncheng Man; Ran An; Daniel A Sheik; Jiandi Wan; Jane A Little; Umut A Gurkan; Francesco M Turrini; Theodosia Kalfa; Philip S Low
Journal:  Br J Haematol       Date:  2020-04-28       Impact factor: 6.998

2.  Reticulocyte and red blood cell deformation triggers specific phosphorylation events.

Authors:  Pedro L Moura; Maria A Lizarralde Iragorri; Olivier Français; Bruno Le Pioufle; Johannes G G Dobbe; Geert J Streekstra; Wassim El Nemer; Ashley M Toye; Timothy J Satchwell
Journal:  Blood Adv       Date:  2019-09-10

3.  Rapid degradation of protein tyrosine phosphatase 1B in sickle cells: Possible contribution to sickle cell membrane weakening.

Authors:  Panae Noomuna; John M Hausman; Ruhani Sansoya; Theodosia Kalfa; Mary Risinger; Philip S Low
Journal:  FASEB J       Date:  2022-06       Impact factor: 5.834

4.  Biophysical and rheological biomarkers of red blood cell physiology and pathophysiology.

Authors:  Umut A Gurkan
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.284

5.  Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia.

Authors:  Kristina Kesely; Panae Noomuna; Michal Vieth; Philip Hipskind; Kasturi Haldar; Antonella Pantaleo; Francesco Turrini; Philip S Low
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

Review 6.  Cell physiology and molecular mechanism of anion transport by erythrocyte band 3/AE1.

Authors:  Michael L Jennings
Journal:  Am J Physiol Cell Physiol       Date:  2021-10-20       Impact factor: 4.249

7.  Imatinib augments standard malaria combination therapy without added toxicity.

Authors:  Huynh Dinh Chien; Antonella Pantaleo; Kristina R Kesely; Panae Noomuna; Karson S Putt; Tran Anh Tuan; Philip S Low; Francesco M Turrini
Journal:  J Exp Med       Date:  2021-08-26       Impact factor: 14.307

8.  Vesiculation of Red Blood Cells in the Blood Bank: A Multi-Omics Approach towards Identification of Causes and Consequences.

Authors:  Joames K Freitas Leal; Edwin Lasonder; Vikram Sharma; Jürgen Schiller; Giuseppina Fanelli; Sara Rinalducci; Roland Brock; Giel Bosman
Journal:  Proteomes       Date:  2020-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.